Juvenile Myelomonocytic Leukemia is the most common myeloprolireative syndrome found in young children. Juvenile Myelomonocytic Leukemia occurs most commonly at 1.8 years and presents symptoms of elevated white blood cells, skin rash, hepatosplenomegaly, lymphadenopathy and a fever. Often patients also have an increased level of hemoglobin F and leukemia cell mutations in an RAS pathway.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Juvenile Myelomonocytic Leukemia below!
For more information on how to use Laverne, please read the How to Guide.
We have 1307 products for the study of Juvenile Myelomonocytic Leukemia that can be applied to Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.